{
    "2018-08-27": [
        [
            {
                "time": "",
                "original_text": "[强于大市评级]医药生物行业研究周报：半年报披露进入最后“冲刺”阶段 紧跟“业绩”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "半年报",
                        "披露",
                        "冲刺",
                        "业绩"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：再次强调可适度乐观 择机布局优质公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "增持",
                        "乐观",
                        "布局",
                        "优质公司"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}